Tauvid

(Flortaucipir F18)

Tauvid

Drug updated on 1/4/2024

Dosage FormInjection (intravenous: 300 MBq/mL to 1,900 MBq/mL (8.1 mCi/mL to 51 mCi/mL) of flortaucipir F 18 injection in a multiple-dose vial)
Drug ClassRadioactive diagnostic agents
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD).

Product Monograph / Prescribing Information

Document TitleYearSource
Tauvid (flortaucipir F18) Prescribing Information.2022Avid Radiopharmaceuticals, Philadelphia, PA